| Robin Shattock | |
| Birth Name: | Robin John Shattock |
| Fields: | Mucosal Infection Immunology |
| Workplaces: | Imperial College London |
| Thesis1 Title: | and |
| Thesis2 Title: | )--> |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis1 Year: | and |
| Thesis2 Year: | )--> |
| Doctoral Advisors: | )--> |
| Spouses: | )--> |
| Partners: | )--> |
Robin John Shattock (born February 1963) is professor of mucosal infection and immunity at the Faculty of Medicine, Imperial College London.[1] [2] [3]
Shattock attended Lancing College, where he was initially more interested in acting and music than science.[4]
During the COVID-19 pandemic, Shattock led the British initiative to develop a vaccine for the disease at Imperial.[5] He estimated in February 2020 that the vaccine for the disease would be available by early 2021.[6]
Shattock was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2017.[3]